Neurofilament light is a biomarker of brain involvement in lupus and primary Sjögren’s syndrome
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1459
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Neurofilament light is a biomarker of brain involvement in lupus and primary Sjögren’s syndrome ; day:30 ; month:10 ; year:2020 ; pages:1-10
Journal of neurology ; (30.10.2020), 1-10
- Creator
-
Tjensvoll, Anne B.
Lauvsnes, Maria B.
Zetterberg, Henrik
Kvaløy, Jan T.
Kvivik, Ingeborg
Maroni, Stian S.
Greve, Ole J.
Beyer, Mona K.
Hirohata, Shunsei
Putterman, Chaim
Alves, Guido
Harboe, Erna
Blennow, Kaj
Gøransson, Lasse G.
Omdal, Roald
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00415-020-10290-y
- URN
-
urn:nbn:de:101:1-2020121322133800136271
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tjensvoll, Anne B.
- Lauvsnes, Maria B.
- Zetterberg, Henrik
- Kvaløy, Jan T.
- Kvivik, Ingeborg
- Maroni, Stian S.
- Greve, Ole J.
- Beyer, Mona K.
- Hirohata, Shunsei
- Putterman, Chaim
- Alves, Guido
- Harboe, Erna
- Blennow, Kaj
- Gøransson, Lasse G.
- Omdal, Roald
- SpringerLink (Online service)
Other Objects (12)
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus
Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Fluid biomarkers in Alzheimer’s disease – current concepts
Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury
Neurofilament light chain as neuronal injury marker – what is needed to facilitate implementation in clinical laboratory practice?
Thirty years after anorexia nervosa onset, serum neurofilament light chain protein concentration indicates neuronal injury
Repeated lumbar punctures within 3 days may affect CSF biomarker levels
BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease
Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus
Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Fluid biomarkers in Alzheimer’s disease – current concepts
Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury
Neurofilament light chain as neuronal injury marker – what is needed to facilitate implementation in clinical laboratory practice?
Thirty years after anorexia nervosa onset, serum neurofilament light chain protein concentration indicates neuronal injury
Repeated lumbar punctures within 3 days may affect CSF biomarker levels
BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease
Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus
Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Fluid biomarkers in Alzheimer’s disease – current concepts
Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury
Neurofilament light chain as neuronal injury marker – what is needed to facilitate implementation in clinical laboratory practice?
Thirty years after anorexia nervosa onset, serum neurofilament light chain protein concentration indicates neuronal injury
Repeated lumbar punctures within 3 days may affect CSF biomarker levels
BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease